Skip to content

Collect therapy coil electrograms from insulation breaches study

Collect therapy coil electrograms from insulATion breaCHes (CATCH) Study: a prospective non-randomized multi-center post-market feasibility study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN10583311
Enrollment
25
Registered
2016-08-17
Start date
2016-07-05
Completion date
Unknown
Last updated
2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Implanted defibrillator lead high-voltage insulation breach Circulatory System

Interventions

Study subjects will wear a telemetry Holter monitor that stores continuous implanted device data for up to 24 hours. The study will be reviewing electrogram (EGM) data collected by the Holter monitor

Sponsors

Medtronic, Inc. (USA)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subject (or subject’s legally authorized representative) is willing and able to provide written informed consent 2. Subject is at least 18 years of age (or older, if required by local law) 3. Subject is willing and able to wear a Holter monitor for at least 2 hours and up to 24 hours 4. Subject has been implanted with a Medtronic ICD or CRT-D device 5. Subject’s defibrillator lead has a possible high voltage insulation breach, as suggested by device diagnostics exhibiting any of the following three characteristics: 5.1. Abrupt high voltage impedance decrease (25% decrease in daily impedance from baseline) 5.2. Non-physiologic noise on high voltage EGM 5.3. Less than 50% programmed shock energy delivered

Exclusion criteria

Exclusion criteria: 1. Subject has medical conditions that would limit study participation (per physician discretion) 2. Subject is enrolled in one or more concurrent studies that would confound the study results of this study as determined by Medtronic

Design outcomes

Primary

MeasureTime frame
Lead insulation breaches in the high-voltage portion of defibrillation leads, measured using EGM data at any time between the end of Holter monitor use to up to 180 days post-Holter use

Secondary

MeasureTime frame
There are no secondary outcome measures for this study

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026